Rein Therapeutics Inc.

NASDAQ: RNTX · Real-Time Price · USD
1.42
-0.05 (-3.40%)
At close: Jun 30, 2025, 3:59 PM
1.40
-1.41%
After-hours: Jun 30, 2025, 04:04 PM EDT

Rein Therapeutics Revenue

Rein Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Rein Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
11
Market Cap
31.46M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.